ANDON HEALTH(SZ:002432) 2 1 Shi Ji Jing Ji Bao Dao·2025-10-22 00:25Core Viewpoint - After the decline of dividends, the company is shifting its focus towards investment opportunities, initiating a second share buyback plan in 2025 to maintain company value and protect shareholder rights [2][3]. Group 1: Share Buyback and Stock Performance - The company announced a share buyback plan on October 14, 2025, intending to use 300 million to 600 million yuan of its own funds and special loans [2]. - Despite the buyback, the company's stock price has decreased over 7% since the last buyback announcement, while the broader market has increased by over 20% during the same period [2]. - The company's stock price has fallen below its latest net asset value per share, prompting the buyback to protect shareholder interests [2]. Group 2: Financial Performance and Investment Strategy - The company experienced a significant increase in net profit, reaching 9.2 billion yuan in the first half of 2025, a year-on-year growth of over 50%, despite a decline in revenue from its core internet medical products and services [5]. - The unusual situation of declining revenue but rising profits is attributed to substantial investment income, with fair value changes contributing 734 million yuan, ten times the previous year's figure [5]. - The company has engaged in various investments, including venture capital funds, with a total estimated investment of approximately 4.363 billion yuan since September 2022 [6]. Group 3: Historical Context and Growth - The company’s growth trajectory began during the COVID-19 pandemic, achieving significant sales increases due to timely inventory management and product demand [4]. - In 2022, the company reported a revenue of 26.315 billion yuan, a staggering increase of 997.8% year-on-year, driven by large orders for COVID-19 testing kits [4]. - The company has received over 2.4 billion USD in orders from U.S. federal and state governments from December 2021 to 2023, marking a significant achievement in the IVD sector [4]. Group 4: Investment Expansion - The company has made strategic investments in various sectors, including hard technology, healthcare, artificial intelligence, and new materials, aiming for long-term returns [6][8]. - Recent investments include acquiring a 20% stake in iHealth from Xiaomi for approximately 459.1 million USD, increasing its ownership to 100% [8]. - The company is also exploring opportunities in the electric vehicle sector, holding shares in several automotive companies, including Tesla and NIO [9].